Filing Details

Accession Number:
0001640455-18-000043
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-03-19 18:42:03
Reporting Period:
2018-03-15
Accepted Time:
2018-03-19 18:42:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1640455 Jounce Therapeutics Inc. JNCE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1353128 Gayle Barbara Duncan C/O Jounce Therapeutics, Inc.
780 Memorial Drive
Cambridge MA 02139
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-03-15 2,000 $4.21 2,000 No 4 M Direct
Common Stock Disposition 2018-03-15 2,000 $28.11 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2018-03-15 2,000 $0.00 2,000 $4.21
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
44,271 2026-05-09 No 4 M Direct
Footnotes
  1. The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 8, 2017. The Reporting Person exercised no discretion with respect to these transactions.
  2. The option shares vest and become exercisable in 16 quarterly installments from May 10, 2016.